T. 07540 549 873 E. info@londonbreast.co.uk

The BRCA genes function to keep breast cells growing normally and to prevent cancer-cell growth.

Mutations of the BRCA1 and BRCA2 gene makes someone susceptible to developing breast and/or ovarian cancer at some point in their life. Mutations in these genes can be passed from either parent to their children.

  • The lifetime risk of developing breast cancer is as high as 84% for women who have inherited a BRCA1 or BRCA2 mutation.
  • The lifetime risk of developing ovarian cancer is as high as 60% for women who carry a BRCA1 or BRCA2 genetic mutation.

A blood test can determine if someone carries a BRCA1 or BRCA2 gene mutation and empower him or her to make informed decision about risk reducing mastectomy. Immediate breast reconstruction is offered to all woman undergoing risk reducing mastectomy. A number of reconstructive options are available in order to provide the most individualized approach.



The aim of BRA Foundation (formerly known as the Didyma Foundation) is to share the best and most current information for cancer patients facing breast reconstruction.